Allspring Global Investments Holdings, LLC Allakos Inc. Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$1.72 - $3.18 $13,567 - $25,083	-7,888 Reduced 35.51%	14,326 $39,000
Q3 2023 Oct 27, 2023	BUY	$2.13 - $5.55 $47,315 - $123,287	22,214 New	22,214 $50,000
Q2 2023 Jul 18, 2023	BUY	$3.6 - $5.25 $133,372 - $194,502	37,048 New	37,048 $161,000
Q2 2022 Jul 25, 2022	SELL	$2.6 - $6.14 $17,329 - $40,923	-6,665 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$5.08 - $9.81 $4,384 - $8,466	-863 Reduced 11.46%	6,665 $37,000
Q4 2021 Jan 28, 2022	BUY	$8.55 - $111.89 $64,364 - $842,307	7,528 New	7,528 $73,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$17.5 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$6.52 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$5.3 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$3.73 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.26 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account